- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
84
Companies with a Value score of at least 3, ordered by Value score
84 companies
BeiGene
Market Cap: HK$28.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$145.70
7D
6.3%
1Y
58.9%
Consun Pharmaceutical Group
Market Cap: HK$8.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.99
7D
5.3%
1Y
49.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.17
7D
1.9%
1Y
-48.7%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.40
7D
3.5%
1Y
-17.4%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.40
7D
3.5%
1Y
-17.4%
WuXi AppTec
Market Cap: HK$177.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$67.65
7D
7.0%
1Y
84.3%
United Laboratories International Holdings
Market Cap: HK$24.4b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.42
7D
1.7%
1Y
48.5%
JW (Cayman) Therapeutics
Market Cap: HK$701.3m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$1.73
7D
3.6%
1Y
-23.5%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.17
7D
1.9%
1Y
-48.7%
SSY Group
Market Cap: HK$8.9b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.01
7D
4.2%
1Y
-34.7%
United Laboratories International Holdings
Market Cap: HK$24.4b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.42
7D
1.7%
1Y
48.5%
WuXi AppTec
Market Cap: HK$177.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$67.65
7D
7.0%
1Y
84.3%
SSY Group
Market Cap: HK$8.9b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.01
7D
4.2%
1Y
-34.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.17
7D
1.9%
1Y
-48.7%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.40
7D
3.5%
1Y
-17.4%
BeiGene
Market Cap: HK$28.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$145.70
7D
6.3%
1Y
58.9%
United Laboratories International Holdings
Market Cap: HK$24.4b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.42
7D
1.7%
1Y
48.5%
SSY Group
Market Cap: HK$8.9b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.01
7D
4.2%
1Y
-34.7%
BeiGene
Market Cap: HK$28.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$145.70
7D
6.3%
1Y
58.9%
WuXi AppTec
Market Cap: HK$177.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$67.65
7D
7.0%
1Y
84.3%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.00
7D
15.1%
1Y
-8.7%
Zai Lab
Market Cap: HK$3.5b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$25.10
7D
9.4%
1Y
77.3%
3SBio
Market Cap: HK$47.3b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$20.05
7D
57.4%
1Y
227.6%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.20
7D
6.3%
1Y
44.7%
PuraPharm
Market Cap: HK$201.5m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.52
7D
8.3%
1Y
-34.2%
Innovent Biologics
Market Cap: HK$96.7b
A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.
1801
HK$58.60
7D
14.9%
1Y
63.2%
Shanghai Henlius Biotech
Market Cap: HK$22.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$42.10
7D
6.3%
1Y
123.5%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.00
7D
15.1%
1Y
-8.7%
WuXi Biologics (Cayman)
Market Cap: HK$96.9b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$23.85
7D
1.3%
1Y
91.7%
Essex Bio-Technology
Market Cap: HK$2.7b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.69
7D
7.6%
1Y
86.9%
WuXi Biologics (Cayman)
Market Cap: HK$96.9b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$23.85
7D
1.3%
1Y
91.7%
Kontafarma China Holdings
Market Cap: HK$173.2m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.03
7D
7.1%
1Y
-33.3%
Abbisko Cayman
Market Cap: HK$5.3b
An investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China.
2256
HK$8.49
7D
3.7%
1Y
154.2%
Innovent Biologics
Market Cap: HK$96.7b
A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.
1801
HK$58.60
7D
14.9%
1Y
63.2%
Zai Lab
Market Cap: HK$3.5b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$25.10
7D
9.4%
1Y
77.3%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$410.7m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.36
7D
10.6%
1Y
66.7%